109 research outputs found
Gene Expression Profiling of Purified Rat Retinal Ganglion Cells
PURPOSE. The phenotype of specialized cells arises, in part, from their characteristic gene expression patterns. Retinal ganglion cells (RGCs) are of wide interest in neuroscience and die in glaucoma and other optic neuropathies. In this study the genes expressed by RGCs were profiled by expressed sequence tag (EST) analysis. METHODS. ESTs were generated from a cDNA library constructed from RGCs isolated by immunopanning. The RGC genes were compared with published microarray expression profiles from 13 different neural regions. Immunohistochemistry was performed by standard methods. RESULTS. Clustering of 4791 RGC ESTs identified 2360 unique gene clusters. Of these, 60% represented known genes, 27% uncharacterized genes/ESTs, and 13% novel sequence. Unexpectedly, one of the largest RGC clusters, RESP18, corresponded to a neuroendocrine-specific gene preferentially expressed in the hypothalamus. RESP18 immunoreactivity within the retina was found mainly in the RGC layer. DDAH1, a gene involved in nitric oxide metabolism, was localized to RGC and amacrine layers. Comparison of gene expression patterns across neuronal regions revealed a prominent subset of RGC genes that were overexpressed in dorsal root and trigeminal ganglia. To narrow the search for candidate disease-related genes, RGC genes were mapped to known disease loci for optic neuropathies. CONCLUSIONS. This work is one of the first efforts to profile gene expression in a purified population of retinal neurons, the RGCs. The profiling, in addition to revealing both known and novel genes underlying the RGC phenotype, also uncovered common patterns of gene expression between RGCs and other sensory ganglia. (Invest Ophthalmol Vis Sci
POTs: Protective Optimization Technologies
Algorithmic fairness aims to address the economic, moral, social, and
political impact that digital systems have on populations through solutions
that can be applied by service providers. Fairness frameworks do so, in part,
by mapping these problems to a narrow definition and assuming the service
providers can be trusted to deploy countermeasures. Not surprisingly, these
decisions limit fairness frameworks' ability to capture a variety of harms
caused by systems.
We characterize fairness limitations using concepts from requirements
engineering and from social sciences. We show that the focus on algorithms'
inputs and outputs misses harms that arise from systems interacting with the
world; that the focus on bias and discrimination omits broader harms on
populations and their environments; and that relying on service providers
excludes scenarios where they are not cooperative or intentionally adversarial.
We propose Protective Optimization Technologies (POTs). POTs provide means
for affected parties to address the negative impacts of systems in the
environment, expanding avenues for political contestation. POTs intervene from
outside the system, do not require service providers to cooperate, and can
serve to correct, shift, or expose harms that systems impose on populations and
their environments. We illustrate the potential and limitations of POTs in two
case studies: countering road congestion caused by traffic-beating
applications, and recalibrating credit scoring for loan applicants.Comment: Appears in Conference on Fairness, Accountability, and Transparency
(FAT* 2020). Bogdan Kulynych and Rebekah Overdorf contributed equally to this
work. Version v1/v2 by Seda G\"urses, Rebekah Overdorf, and Ero Balsa was
presented at HotPETS 2018 and at PiMLAI 201
Household Responses to School Closure Resulting from Outbreak of Influenza B, North Carolina
Parents accepted school closure during an outbreak, but children’s presence in other public settings has implications for pandemic planning
Recommended from our members
To arm or to ally? The patron's dilemma and the strategic logic of arms transfers and alliances
How do great powers decide whether to provide arms to or form alliances with client states? This “patron's dilemma” revolves around a decision about how to best provide security to clients without becoming entrapped in unwanted conflicts. Strong commitments worsen the risk of entrapment, whereas weak commitments intensify fears of abandonment. This traditional alliance dilemma can be addressed through the provision of arms and alliances. Great power patrons primarily make such decisions on the basis of two factors: first, the extent to which the patron believes it and its client have common security interests; and second, whether the patron believes that its client has sufficient military capabilities to deter its main adversary without the patron's assistance. Patrons assess the degree of shared threat and the local balances of capabilities in determining whether to support their clients with arms, alliances, or both. As demonstrated in the U.S. provision of security goods to Taiwan and Israel during the Cold War, this strategic logic explains how great powers manage the patron's dilemma
International AIDS Society global scientific strategy: towards an HIV cure 2016
Antiretroviral therapy is not curative. Given the challenges in providing life-long therapy to a global population of over 35 million people living with HIV, there is intense interest in developing a cure for HIV infection. The International AIDS Society convened a group of international experts to develop a scientific strategy for research towards an HIV cure. This Perspective summarizes the group's strategy
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
SummaryWe describe a comprehensive genomic characterization of adrenocortical carcinoma (ACC). Using this dataset, we expand the catalogue of known ACC driver genes to include PRKAR1A, RPL22, TERF2, CCNE1, and NF1. Genome wide DNA copy-number analysis revealed frequent occurrence of massive DNA loss followed by whole-genome doubling (WGD), which was associated with aggressive clinical course, suggesting WGD is a hallmark of disease progression. Corroborating this hypothesis were increased TERT expression, decreased telomere length, and activation of cell-cycle programs. Integrated subtype analysis identified three ACC subtypes with distinct clinical outcome and molecular alterations which could be captured by a 68-CpG probe DNA-methylation signature, proposing a strategy for clinical stratification of patients based on molecular markers
International AIDS Society global scientific strategy: towards an HIV cure 2016
Antiretroviral therapy is not curative. Given the challenges in providing lifelong therapy to a global population of more than 35 million people living with HIV, there is intense interest in developing a cure for HIV infection. The International AIDS Society convened a group of international experts to develop a scientific strategy for research towards an HIV cure. This Perspective summarizes the group's strategy
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
Invasive lobular carcinoma (ILC) is the second most prevalent histologic subtype of invasive breast cancer. Here, we comprehensively profiled 817 breast tumors, including 127 ILC, 490 ductal (IDC), and 88 mixed IDC/ILC. Besides E-cadherin loss, the best known ILC genetic hallmark, we identified mutations targeting PTEN, TBX3 and FOXA1 as ILC enriched features. PTEN loss associated with increased AKT phosphorylation, which was highest in ILC among all breast cancer subtypes. Spatially clustered FOXA1 mutations correlated with increased FOXA1 expression and activity. Conversely, GATA3 mutations and high expression characterized Luminal A IDC, suggesting differential modulation of ER activity in ILC and IDC. Proliferation and immune-related signatures determined three ILC transcriptional subtypes associated with survival differences. Mixed IDC/ILC cases were molecularly classified as ILC-like and IDC-like revealing no true hybrid features. This multidimensional molecular atlas sheds new light on the genetic bases of ILC and provides potential clinical options
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
We describe the landscape of somatic genomic alterations of 66 chromophobe renal cell carcinomas (ChRCCs) based on multidimensional and comprehensive characterization, including mitochondrial DNA (mtDNA) and whole genome sequencing. The result is consistent that ChRCC originates from the distal nephron compared to other kidney cancers with more proximal origins. Combined mtDNA and gene expression analysis implicates changes in mitochondrial function as a component of the disease biology, while suggesting alternative roles for mtDNA mutations in cancers relying on oxidative phosphorylation. Genomic rearrangements lead to recurrent structural breakpoints within TERT promoter region, which correlates with highly elevated TERT expression and manifestation of kataegis, representing a mechanism of TERT up-regulation in cancer distinct from previously-observed amplifications and point mutations
Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin
Recent genomic analyses of pathologically-defined tumor types identify “within-a-tissue” disease subtypes. However, the extent to which genomic signatures are shared across tissues is still unclear. We performed an integrative analysis using five genome-wide platforms and one proteomic platform on 3,527 specimens from 12 cancer types, revealing a unified classification into 11 major subtypes. Five subtypes were nearly identical to their tissue-of-origin counterparts, but several distinct cancer types were found to converge into common subtypes. Lung squamous, head & neck, and a subset of bladder cancers coalesced into one subtype typified by TP53 alterations, TP63 amplifications, and high expression of immune and proliferation pathway genes. Of note, bladder cancers split into three pan-cancer subtypes. The multi-platform classification, while correlated with tissue-of-origin, provides independent information for predicting clinical outcomes. All datasets are available for data-mining from a unified resource to support further biological discoveries and insights into novel therapeutic strategies
- …